September 5, 2017

FDA Approves Mylotarg for Adults and Children with AML

News

The U.S. Food and Drug Administration has approved Pfizer’s Mylotarg (gemtuzumab ozogamicin) for adults and children with acute myeloid leukemia (AML) whose cancer carries the CD33 marker. In adults, Mylotarg ... Read more

July 13, 2017

FDA Committee Recommends Approval of Mylotarg to Treat Newly Diagnosed AML

News

The Oncologic Drug Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) supports the approval of Pfizer’s Mylotarg (gemtuzumab ozogamicin), in combination with standard chemotherapy, for the treatment ... Read more